Atea Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AVIR on Nasdaq
Insider Sale
+$233,615
-0.96%
Shares
Shares Volume: 57,969 Shares
Average Share Price: $4.03
INSIDER
Sommadossi Jean-Pierre
President, CEO, and Chairman (Director)
reported on Sep 19 2024
traded on Sep 17 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 5,982,582 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $152,247.52 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 9 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $87,435.23 |
| COMPANY PREVIOUS TRADES |